Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 635

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Gene Therapy for Cancer: What Have We Done and Where Are We Going?

Roth, J. A., Cristiano, R. J.·1997·JNCI Journal of the National Cancer Institute

Abstract

Gene-based therapies for cancer in clinical trials include strategies that involve augmentation of immunotherapeutic and chemotherapeutic approaches. These strategies include ex vivo and in vivo cytokine gene transfer, drug sensitization with genes for prodrug delivery, and the use of drug-resistance genes for bone marrow protection from high-dose chemotherapy. Inactivation of oncogene expression and gene replacement for tumor suppressor genes are among the strategies for targeting the underlying genetic lesions in the cancer cell. A review of clinical trial results to date, primarily in patients with very advanced cancers refractory to conventional treatments, indicates that these treatments can mediate tumor regression with acceptably low toxicity. Vector development remains a critical area for future research. Important areas for future research include modifying viral vectors to reduce toxicity and immunogenicity, increasing the transduction efficiency of nonviral vectors, enhancing vector targeting and specificity, regulating gene expression, and identifying synergies between gene-based agents and other cancer therapeutics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/89.1.21

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 147

  1. Blaese, 1995, Science, 270, 475, 10.1126/science.270.5235.475 · DOI · Paper page
  2. Kiem, 1995, Current opinion in oncology, 7, 107, 10.1097/00001622-199503000-00003 · doi:10.1097/00001622-199503000-00003
  3. Miller, 1995, The FASEB Journal, 9, 190, 10.1096/fasebj.9.2.7781922 · DOI · Paper page
  4. Crystal, 1995, Science, 270, 404, 10.1126/science.270.5235.404 · DOI · Paper page
  5. Herrmann, 1995, Journal of molecular medicine (Berlin, Germany), 73, 157
  6. Descamps, 1996, Journal of molecular medicine (Berlin, Germany), 74, 183, 10.1007/s001090050021 · doi:10.1007/s001090050021
  7. 1995, Cancer gene therapy, 4, 291
  8. Torres, 1995, Human gene therapy, 6, 133, 10.1089/hum.1995.6.2-133 · doi:10.1089/hum.1995.6.2-133
  9. Fearon, 1990, Cell, 60, 397, 10.1016/0092-8674(90)90591-2 · DOI · Paper page
  10. Asher, 1991, The Journal of Immunology, 146, 3227, 10.4049/jimmunol.146.9.3227 · DOI · Paper page
  11. Golumbek, 1991, Science, 254, 713, 10.1126/science.1948050 · DOI · Paper page
  12. Gansbacher, 1990, Cancer Research, 50, 7820
  13. Gansbacher, 1990, Journal of Experimental Medicine, 172, 1217, 10.1084/jem.172.4.1217 · DOI · Paper page
  14. Karp, 1993, The Journal of Immunology, 150, 896, 10.4049/jimmunol.150.3.896 · DOI
  15. Porgador, 1993, International journal of cancer. Journal international du cancer, 53, 471, 10.1002/ijc.2910530320 · doi:10.1002/ijc.2910530320
  16. Tsai, 1993, JNCI Journal of the National Cancer Institute, 85, 546, 10.1093/jnci/85.7.546 · doi:10.1093/jnci/85.7.546
  17. Restifo, 1992, Journal of Experimental Medicine, 175, 1423, 10.1084/jem.175.6.1423 · DOI · Paper page
  18. Gastl, 1992, Cancer Research, 52, 6229
  19. Gansbacher, 1992, Blood, 80, 2817, 10.1182/blood.V80.11.2817.2817 · doi:10.1182/blood.v80.11.2817.2817
  20. Merrouche, 1995, Journal of Clinical Oncology, 13, 410, 10.1200/JCO.1995.13.2.410 · DOI
  21. Sanda, 1995, JNCI Journal of the National Cancer Institute, 87, 280, 10.1093/jnci/87.4.280 · DOI · Paper page
  22. 1995, Scientific American, 1, 90
  23. Lehmann, 1995, European journal of immunology, 25, 340, 10.1002/eji.1830250206 · DOI · Paper page
  24. Grimm, 1988, Cancer immunology, immunotherapy : CII, 27, 53, 10.1007/BF00205758 · doi:10.1007/bf00205758
  25. Herrmann, 1996, Journal of molecular medicine (Berlin, Germany), 74, 213, 10.1007/BF00204751 · doi:10.1007/bf00204751
  26. Culver, 1992, Science, 256, 1550, 10.1126/science.1317968 · DOI · Paper page
  27. Freeman, 1993, Cancer Research, 53, 5274
  28. Bi, 1993, Human gene therapy, 4, 725, 10.1089/hum.1993.4.6-725 · DOI · Paper page
  29. Vile, 1994, Cancer Research, 54, 6228
  30. Hirschowitz, 1995, Human gene therapy, 6, 1055, 10.1089/hum.1995.6.8-1055 · doi:10.1089/hum.1995.6.8-1055
  31. Khil, 1996, Clinical Cancer Research, 2, 53
  32. 1995, Cancer gene therapy, 2, 67
  33. 1995, Human gene therapy, 6, 535, 10.1089/hum.1995.6.4-535 · doi:10.1089/hum.1995.6.4-535
  34. Mickisch, 1992, Blood, 79, 1087, 10.1182/blood.V79.4.1087.bloodjournal7941087 · DOI
  35. Sorrentino, 1992, Science, 257, 99, 10.1126/science.1352414 · DOI · Paper page
  36. Moritz, 1995, Cancer Research, 55, 2608
  37. May, 1995, Blood, 86, 2439, 10.1182/blood.V86.6.2439.bloodjournal8662439 · DOI
  38. Spencer, 1996, Blood, 87, 2579, 10.1182/blood.V87.6.2579.bloodjournal8762579 · DOI
  39. Weinberg, 1991, Science, 254, 1138, 10.1126/science.1659741 · DOI · Paper page
  40. Bishop, 1991, Cell, 64, 235, 10.1016/0092-8674(91)90636-D · DOI · Paper page
  41. Marshall, 1991, Trends in genetics : TIG, 7, 91, 10.1016/0168-9525(91)90278-X · DOI
  42. Mukhopadhyay, 1991, Cancer Research, 51, 1744
  43. Calabretta, 1991, Cancer Research, 51, 4505
  44. Zhang, 1993, Human gene therapy, 4, 451, 10.1089/hum.1993.4.4-451 · DOI
  45. Georges, 1993, Cancer Research, 53, 1743
  46. 1994, Cancer gene therapy, 1, 333
  47. Kashani-Sabet, 1994, Cancer Research, 54, 900
  48. Scanlon, 1991, PNAS, 88, 10591, 10.1073/pnas.88.23.10591 · DOI · Paper page
  49. Feng, 1995, Cancer Research, 55, 2024
  50. 1991, 30, 8283, 10.1021/bi00098a001 · DOI
  51. Richardson, 1995, Trends in biotechnology, 13, 306, 10.1016/S0167-7799(00)88970-2 · DOI
  52. Knudson, 1990, Cancer Research, 50, 6765
  53. Liebermann, 1995, Oncogene, 11, 199
  54. Takahashi, 1992, Cancer Research, 52, 2340
  55. Goyette, 1992, Molecular and Cellular Biology, 12, 1387, 10.1128/MCB.12.3.1387 · DOI · Paper page
  56. Cai, 1993, Human gene therapy, 4, 617, 10.1089/hum.1993.4.5-617 · DOI
  57. Fujiwara, 1994, JNCI Journal of the National Cancer Institute, 86, 1458, 10.1093/jnci/86.19.1458 · DOI · Paper page
  58. Wang, 1995, Cancer gene therapy, 2, 9
  59. Liu, 1994, Cancer Research, 54, 3662
  60. Clayman, 1995, Cancer Research, 55, 1
  61. 1995, 36, 423
  62. 1995, 36, 423
  63. Werthman, 1996, The Journal of urology, 155, 753, 10.1016/S0022-5347(01)66515-7 · DOI
  64. Badie, 1995, Neurological research, 17, 209, 10.1080/01616412.1995.11740314 · DOI
  65. Drazan, 1994, Surgery, 116, 197
  66. Harris, 1996, Cancer gene therapy, 3, 121
  67. Jin, 1995, Cancer Research, 55, 3250
  68. Xu, 1996, Cancer Research, 56, 2245
  69. Rusch, 1995, Cancer Research, 55, 5038
  70. Lowe, 1993, Cell, 74, 957, 10.1016/0092-8674(93)90719-7 · DOI · Paper page
  71. Fujiwara, 1994, Cancer Research, 54, 2287
  72. 1993, Human gene therapy, 4, 451, 10.1089/hum.1993.4.4-451 · DOI
  73. Fujiwara, 1993, Cancer Research, 53, 4129
  74. 1995, Biotechnology (Reading, Mass.), 13, 222
  75. 1995, TUMOR TARGETING, 1, 295
  76. 1988, 167, 400, 10.1016/0042-6822(88)90101-8 · doi:10.1016/0042-6822(88)90101-8 · Paper page
  77. 1994, Blood, 84, 359a
  78. 1995, Cancer gene therapy, 2, 323
  79. 1995, Gut, 37, A133
  80. Li, 1993, Human gene therapy, 4, 403, 10.1089/hum.1993.4.4-403 · DOI · Paper page
  81. 1995, 210, 226, 10.1006/viro.1995.1337 · DOI
  82. Kremer, 1995, British Medical Bulletin, 51, 31, 10.1093/oxfordjournals.bmb.a072951 · DOI
  83. Engelhardt, 1993, Human gene therapy, 4, 759, 10.1089/hum.1993.4.6-759 · DOI · Paper page
  84. 1995, Cancer gene therapy, 2, 225
  85. Engelhardt, 1994, PNAS, 91, 6196, 10.1073/pnas.91.13.6196 · DOI · Paper page
  86. Yang, 1994, PNAS, 91, 4407, 10.1073/pnas.91.10.4407 · DOI · Paper page
  87. Engelhardt, 1994, Human gene therapy, 5, 1217, 10.1089/hum.1994.5.10-1217 · DOI · Paper page
  88. 1996, 217, 11, 10.1006/viro.1996.0088 · DOI · Paper page
  89. Yang, 1995, Nature medicine, 1, 890, 10.1038/nm0995-890 · DOI · Paper page
  90. Dai, 1995, PNAS, 92, 1401, 10.1073/pnas.92.5.1401 · DOI · Paper page
  91. Fang, 1995, Human gene therapy, 6, 1039, 10.1089/hum.1995.6.8-1039 · DOI
  92. Roth, 1996, Human gene therapy, 7, 861, 10.1089/hum.1996.7.7-861 · doi:10.1089/hum.1996.7.7-861
  93. Flotte, 1993, PNAS, 90, 10613, 10.1073/pnas.90.22.10613 · DOI · Paper page
  94. Halbert, 1995, Journal of Virology, 69, 1473, 10.1128/JVI.69.3.1473-1479.1995 · DOI
  95. Latchman, 1994, Molecular biotechnology, 2, 179, 10.1007/BF02824809 · DOI
  96. Peplinski, 1995, Annals of Surgical Oncology, 2, 151, 10.1007/BF02303631 · doi:10.1007/bf02303631
  97. Hodge, 1994, Cancer Research, 54, 5552
  98. Wilkinson, 1995, British Medical Bulletin, 51, 205, 10.1093/oxfordjournals.bmb.a072947 · doi:10.1093/oxfordjournals.bmb.a072947
  99. Forstov, 1995, Human gene therapy, 6, 297, 10.1089/hum.1995.6.3-297 · doi:10.1089/hum.1995.6.3-297
  100. Nabel, 1992, Human gene therapy, 3, 649, 10.1089/hum.1992.3.6-649 · doi:10.1089/hum.1992.3.6-649
  101. Das, 1985, Biochemical medicine, 33, 124, 10.1016/0006-2944(85)90135-8 · doi:10.1016/0006-2944(85)90135-8
  102. Wu, 1987, Journal of Biological Chemistry, 262, 4429, 10.1016/S0021-9258(18)61209-8 · DOI · Paper page
  103. Wagner, 1990, PNAS, 87, 3410, 10.1073/pnas.87.9.3410 · DOI · Paper page
  104. Cristiano, 1993, PNAS, 90, 11548, 10.1073/pnas.90.24.11548 · DOI · Paper page
  105. Bunnell, 1992, Somatic cell and molecular genetics, 18, 559, 10.1007/BF01232652 · DOI
  106. Cotten, 1992, PNAS, 89, 6094, 10.1073/pnas.89.13.6094 · DOI · Paper page
  107. Gao, 1993, Human gene therapy, 4, 17, 10.1089/hum.1993.4.1-17 · doi:10.1089/hum.1993.4.1-17
  108. Davis, 1993, Human gene therapy, 4, 151, 10.1089/hum.1993.4.2-151 · DOI · Paper page
  109. Acsadi, 1991, The New biologist, 3, 71
  110. Cheng, 1993, PNAS, 90, 4455, 10.1073/pnas.90.10.4455 · DOI · Paper page
  111. Nicolet, 1995, Cancer gene therapy, 2, 161
  112. Miller, 1990, Molecular and Cellular Biology, 10, 4239, 10.1128/MCB.10.8.4239 · DOI · Paper page
  113. 1993, PNAS, 90, 11548, 10.1073/pnas.90.24.11548 · DOI · Paper page
  114. Curiel, 1992, Human gene therapy, 3, 147, 10.1089/hum.1992.3.2-147 · DOI · Paper page
  115. Kasahara, 1994, Science, 266, 1373, 10.1126/science.7973726 · doi:10.1126/science.7973726
  116. Gottschalk, 1994, Gene therapy, 1, 185
  117. Ding, 1995, Journal of Biological Chemistry, 270, 3667, 10.1074/jbc.270.8.3667 · doi:10.1074/jbc.270.8.3667
  118. Cristiano, 1996, Cancer gene therapy, 3, 4
  119. Muller, 1995, Journal of Virology, 69, 948, 10.1128/JVI.69.2.948-954.1995 · doi:10.1128/jvi.69.2.948-954.1995
  120. Ghazal, 1987, PNAS, 84, 3658, 10.1073/pnas.84.11.3658 · DOI
  121. Ponder, 1991, Human gene therapy, 2, 41, 10.1089/hum.1991.2.1-41 · doi:10.1089/hum.1991.2.1-41
  122. DiMaio, 1994, Surgery, 116, 205
  123. Smith, 1994, Human gene therapy, 5, 29, 10.1089/hum.1994.5.1-29 · doi:10.1089/hum.1994.5.1-29
  124. Vile, 1993, Cancer Research, 53, 962
  125. Gazit, 1995, Cancer Research, 55, 1660
  126. Wills, 1994, Human gene therapy, 5, 1079, 10.1089/hum.1994.5.9-1079 · DOI · Paper page
  127. Smythe, 1994, The Annals of Thoracic Surgery, 57, 1395, 10.1016/0003-4975(94)90090-6 · DOI
  128. Zatloukal, 1995, The Journal of Immunology, 154, 3406, 10.4049/jimmunol.154.7.3406 · DOI
  129. Bernad, 1994, British journal of haematology, 87, 6, 10.1111/j.1365-2141.1994.tb04863.x · doi:10.1111/j.1365-2141.1994.tb04863.x
  130. Cole, 1995, Cancer Research, 55, 748
  131. 1995, Journal of molecular medicine (Berlin, Germany), 73, B13
  132. Rosenfeld, 1994, Human gene therapy, 5, 331, 10.1089/hum.1994.5.3-331 · DOI
  133. Weichselbaum, 1994, Cancer Research, 54, 4266
  134. Son, 1994, PNAS, 91, 12669, 10.1073/pnas.91.26.12669 · DOI
  135. Chen, 1995, PNAS, 92, 2577, 10.1073/pnas.92.7.2577 · DOI · Paper page
  136. Crystal, 1994, Nature genetics, 8, 42, 10.1038/ng0994-42 · DOI · Paper page
  137. Ginsberg, 1990, PNAS, 87, 6191, 10.1073/pnas.87.16.6191 · DOI
  138. Ginsberg, 1991, PNAS, 88, 1651, 10.1073/pnas.88.5.1651 · DOI · Paper page
  139. Ginsberg, 1989, PNAS, 86, 3823, 10.1073/pnas.86.10.3823 · DOI · Paper page
  140. Zhang, 1995, Human gene therapy, 6, 155, 10.1089/hum.1995.6.2-155 · DOI
  141. Casson, 1991, Cancer Research, 51, 4495
  142. Bennett, 1993, Cancer Research, 53, 4817
  143. Stribling, 1992, PNAS, 89, 11277, 10.1073/pnas.89.23.11277 · DOI · Paper page
  144. Nabel, 1994, Human gene therapy, 5, 1089, 10.1089/hum.1994.5.9-1089 · DOI
  145. Sobol, 1995, Gene therapy, 2, 164
  146. Habib, 1996, Cancer detection and prevention, 20, 103
  147. Roth, 1996, Nature medicine, 2, 985, 10.1038/nm0996-985 · DOI · Paper page

Cited by

See all 635

Metadata

Authors
Roth, J. A., & Cristiano, R. J.
Venue
JNCI Journal of the National Cancer Institute
Published
1997-01-01
Volume
89
Issue
1
Pages
21-39
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2121421904
Cited by
635
References
2
FWCI
49.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Therapy for Cancer: What Have We Done and Where Are We Going? https://app.cochat.ai/papers/10.1093/jnci/89.1.21
The paper
Roth, J. A., & Cristiano, R. J. (1997). Gene Therapy for Cancer: What Have We Done and Where Are We Going? JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/89.1.21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.